_id
6915fc1bbc934aba376b2771
Ticker
SNSE
Name
Sensei Biotherapeutics Inc
Exchange
NASDAQ
Address
1405 Research Boulevard, Rockville, MD, United States, 20850
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.senseibio.com
Description
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. It also offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. It has a collaboration with The University of Washington to conduct preclinical studies for its solnerstotug program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Last Close
9
Volume
24565
Current Price
8.55
Change
-4.999999999999992
Last Updated
2025-12-04T13:19:22.396Z
Image
-
Ipo Date
2021-02-04T00:00:00.000Z
Market Cap
10973223
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-0.876
Sentiment Sources
1
Rating
5
Target Price
32.5
Strong Buy
2
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
-4851000
Cost Of Revenue
-4851000
Gross Profit
-
Operating Expenses
4851000
Operating Income
-4851000
Interest Expense
6000
Pretax Income
-4569000
Net Income
-4569000
Eps
-3.6224817448802415
Dividends Per Share
-
Shares Outstanding
1261290
Income Tax Expense
-
EBITDA
-4529000
Operating Margin
100
Total Other Income Expense Net
282000
Cash
10562000
Short Term Investments
14479000
Receivables
-
Inventories
-
Total Current Assets
25785000
Property Plant Equipment
1786000
Total Assets
27589000
Payables
306000
Short Term Debt
1875000
Long Term Debt
-
Total Liabilities
4582000
Equity
23007000
Depreciation
34000
Change In Working Capital
2347000
Cash From Operations
-3586000
Capital Expenditures
0
Cash From Investing
1743000
Cash From Financing
-152000
Net Change In Cash
-1995000
PE
-
PB
0.46872819142000266
ROE
-19.859173295084105
ROA
-16.560948203994347
FCF
-3586000
Fcf Percent
0.7392290249433107
Piotroski FScore
1
Health Score
52
Deep Value Investing Score
8
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
6.8
Garp Investing Score
3.5
Growth Investing Score
2
Momentum Investing Score
4.5
Net Net Investing Score
8
Quality Investing Score
6
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
-4851000
Quarters > 0 > income Statement > cost Of Revenue
-4851000
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
4851000
Quarters > 0 > income Statement > operating Income
-4851000
Quarters > 0 > income Statement > interest Expense
6000
Quarters > 0 > income Statement > pretax Income
-4569000
Quarters > 0 > income Statement > net Income
-4569000
Quarters > 0 > income Statement > eps
-3.6224817448802415
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1261290
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-4529000
Quarters > 0 > income Statement > operating Margin
100
Quarters > 0 > income Statement > total Other Income Expense Net
282000
Quarters > 0 > balance Sheet > cash
10562000
Quarters > 0 > balance Sheet > short Term Investments
14479000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
25785000
Quarters > 0 > balance Sheet > property Plant Equipment
1786000
Quarters > 0 > balance Sheet > total Assets
27589000
Quarters > 0 > balance Sheet > payables
306000
Quarters > 0 > balance Sheet > short Term Debt
1875000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4582000
Quarters > 0 > balance Sheet > equity
23007000
Quarters > 0 > cash Flow > net Income
-4568000
Quarters > 0 > cash Flow > depreciation
34000
Quarters > 0 > cash Flow > change In Working Capital
2347000
Quarters > 0 > cash Flow > cash From Operations
-3586000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
1743000
Quarters > 0 > cash Flow > cash From Financing
-152000
Quarters > 0 > cash Flow > net Change In Cash
-1995000
Quarters > 0 > ratios > PE
-3.6224817448802415
Quarters > 0 > ratios > PB
0.46872819142000266
Quarters > 0 > ratios > ROE
-19.859173295084105
Quarters > 0 > ratios > ROA
-16.560948203994347
Quarters > 0 > ratios > FCF
-3586000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
0.7392290249433107
Quarters > 0 > health Score
52
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
37000
Quarters > 1 > income Statement > gross Profit
-37000
Quarters > 1 > income Statement > operating Expenses
5169000
Quarters > 1 > income Statement > operating Income
-5206000
Quarters > 1 > income Statement > interest Expense
10000
Quarters > 1 > income Statement > pretax Income
-4936000
Quarters > 1 > income Statement > net Income
-4936000
Quarters > 1 > income Statement > eps
-3.914766585214777
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1260867
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4889000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
270000
Quarters > 1 > balance Sheet > cash
12557000
Quarters > 1 > balance Sheet > short Term Investments
16071000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
29572000
Quarters > 1 > balance Sheet > property Plant Equipment
2187000
Quarters > 1 > balance Sheet > total Assets
31783000
Quarters > 1 > balance Sheet > payables
351000
Quarters > 1 > balance Sheet > short Term Debt
1963000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4469000
Quarters > 1 > balance Sheet > equity
27314000
Quarters > 1 > cash Flow > net Income
-4936000
Quarters > 1 > cash Flow > depreciation
37000
Quarters > 1 > cash Flow > change In Working Capital
-1488000
Quarters > 1 > cash Flow > cash From Operations
-5909000
Quarters > 1 > cash Flow > capital Expenditures
16000
Quarters > 1 > cash Flow > cash From Investing
8757000
Quarters > 1 > cash Flow > cash From Financing
-168000
Quarters > 1 > cash Flow > net Change In Cash
2680000
Quarters > 1 > ratios > PE
-3.914766585214777
Quarters > 1 > ratios > PB
0.39468451526689613
Quarters > 1 > ratios > ROE
-18.0713187376437
Quarters > 1 > ratios > ROA
-15.53031494824277
Quarters > 1 > ratios > FCF
-5925000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
30000
Quarters > 2 > income Statement > gross Profit
-30000
Quarters > 2 > income Statement > operating Expenses
7244000
Quarters > 2 > income Statement > operating Income
-7274000
Quarters > 2 > income Statement > interest Expense
13000
Quarters > 2 > income Statement > pretax Income
-6864000
Quarters > 2 > income Statement > net Income
-6864000
Quarters > 2 > income Statement > eps
-0.2724635239655764
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
25192363
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-6821000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
410000
Quarters > 2 > balance Sheet > cash
9877000
Quarters > 2 > balance Sheet > short Term Investments
24454000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
35682000
Quarters > 2 > balance Sheet > property Plant Equipment
2567000
Quarters > 2 > balance Sheet > total Assets
38273000
Quarters > 2 > balance Sheet > payables
361000
Quarters > 2 > balance Sheet > short Term Debt
2151000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
6286000
Quarters > 2 > balance Sheet > equity
31987000
Quarters > 2 > cash Flow > net Income
-6864000
Quarters > 2 > cash Flow > depreciation
34000
Quarters > 2 > cash Flow > change In Working Capital
-859000
Quarters > 2 > cash Flow > cash From Operations
-7094000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
7191000
Quarters > 2 > cash Flow > cash From Financing
-214000
Quarters > 2 > cash Flow > net Change In Cash
-117000
Quarters > 2 > ratios > PE
-0.2724635239655764
Quarters > 2 > ratios > PB
6.733820103479538
Quarters > 2 > ratios > ROE
-21.458717604026635
Quarters > 2 > ratios > ROA
-17.93431400726361
Quarters > 2 > ratios > FCF
-7094000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
544000
Quarters > 3 > income Statement > cost Of Revenue
139000
Quarters > 3 > income Statement > gross Profit
-139000
Quarters > 3 > income Statement > operating Expenses
7184000
Quarters > 3 > income Statement > operating Income
-7323000
Quarters > 3 > income Statement > interest Expense
17000
Quarters > 3 > income Statement > pretax Income
-7770000
Quarters > 3 > income Statement > net Income
-7770000
Quarters > 3 > income Statement > eps
-0.30876166663110144
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
25165041
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-7614000
Quarters > 3 > income Statement > operating Margin
-1346.139705882353
Quarters > 3 > income Statement > total Other Income Expense Net
-447000
Quarters > 3 > balance Sheet > cash
9994000
Quarters > 3 > balance Sheet > short Term Investments
31341000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
41929000
Quarters > 3 > balance Sheet > property Plant Equipment
3384000
Quarters > 3 > balance Sheet > total Assets
45361000
Quarters > 3 > balance Sheet > payables
1248000
Quarters > 3 > balance Sheet > short Term Debt
2318000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
6975000
Quarters > 3 > balance Sheet > equity
38386000
Quarters > 3 > cash Flow > net Income
-7770000
Quarters > 3 > cash Flow > depreciation
331000
Quarters > 3 > cash Flow > change In Working Capital
250000
Quarters > 3 > cash Flow > cash From Operations
-5792000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-3151000
Quarters > 3 > cash Flow > cash From Financing
-194000
Quarters > 3 > cash Flow > net Change In Cash
-9137000
Quarters > 3 > ratios > PE
-0.30876166663110144
Quarters > 3 > ratios > PB
5.605197221643308
Quarters > 3 > ratios > ROE
-20.24175480643985
Quarters > 3 > ratios > ROA
-17.12925200061727
Quarters > 3 > ratios > FCF
-5792000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-10.647058823529411
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
551000
Annuals > 0 > income Statement > gross Profit
-551000
Annuals > 0 > income Statement > operating Expenses
31112000
Annuals > 0 > income Statement > operating Income
-31663000
Annuals > 0 > income Statement > interest Expense
90000
Annuals > 0 > income Statement > pretax Income
-30157000
Annuals > 0 > income Statement > net Income
-30157000
Annuals > 0 > income Statement > eps
-1.2006609069554486
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
25117000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-29516000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1506000
Annuals > 0 > balance Sheet > cash
9994000
Annuals > 0 > balance Sheet > short Term Investments
31341000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
41929000
Annuals > 0 > balance Sheet > property Plant Equipment
3384000
Annuals > 0 > balance Sheet > total Assets
45361000
Annuals > 0 > balance Sheet > payables
1248000
Annuals > 0 > balance Sheet > short Term Debt
2318000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
6975000
Annuals > 0 > balance Sheet > equity
38386000
Annuals > 0 > cash Flow > net Income
-30157000
Annuals > 0 > cash Flow > depreciation
1322000
Annuals > 0 > cash Flow > change In Working Capital
-489000
Annuals > 0 > cash Flow > cash From Operations
-24670000
Annuals > 0 > cash Flow > capital Expenditures
146000
Annuals > 0 > cash Flow > cash From Investing
22440000
Annuals > 0 > cash Flow > cash From Financing
-787000
Annuals > 0 > cash Flow > net Change In Cash
-3017000
Annuals > 0 > ratios > PE
-1.2006609069554486
Annuals > 0 > ratios > PB
5.692645756265304
Annuals > 0 > ratios > ROE
-78.56249674360444
Annuals > 0 > ratios > ROA
-66.48222040960296
Annuals > 0 > ratios > FCF
-24816000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
571000
Annuals > 1 > income Statement > gross Profit
-571000
Annuals > 1 > income Statement > operating Expenses
36493000
Annuals > 1 > income Statement > operating Income
-37064000
Annuals > 1 > income Statement > interest Expense
144000
Annuals > 1 > income Statement > pretax Income
-34101000
Annuals > 1 > income Statement > net Income
-34101000
Annuals > 1 > income Statement > eps
-1.2199468555217807
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
27952857
Annuals > 1 > income Statement > income Tax Expense
100000
Annuals > 1 > income Statement > EBITDA
-33386000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
2963000
Annuals > 1 > balance Sheet > cash
13011000
Annuals > 1 > balance Sheet > short Term Investments
52746000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
67250000
Annuals > 1 > balance Sheet > property Plant Equipment
7038000
Annuals > 1 > balance Sheet > total Assets
74374000
Annuals > 1 > balance Sheet > payables
1694000
Annuals > 1 > balance Sheet > short Term Debt
2439000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
9479000
Annuals > 1 > balance Sheet > equity
64895000
Annuals > 1 > cash Flow > net Income
-34101000
Annuals > 1 > cash Flow > depreciation
1351000
Annuals > 1 > cash Flow > change In Working Capital
-4330000
Annuals > 1 > cash Flow > cash From Operations
-32023000
Annuals > 1 > cash Flow > capital Expenditures
180000
Annuals > 1 > cash Flow > cash From Investing
38412000
Annuals > 1 > cash Flow > cash From Financing
-11173000
Annuals > 1 > cash Flow > net Change In Cash
-4784000
Annuals > 1 > ratios > PE
-1.2199468555217807
Annuals > 1 > ratios > PB
3.7474359488404345
Annuals > 1 > ratios > ROE
-52.547962092611144
Annuals > 1 > ratios > ROA
-45.85070051362035
Annuals > 1 > ratios > FCF
-32203000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1808000
Annuals > 2 > income Statement > gross Profit
-1808000
Annuals > 2 > income Statement > operating Expenses
50188000
Annuals > 2 > income Statement > operating Income
-50188000
Annuals > 2 > income Statement > interest Expense
219000
Annuals > 2 > income Statement > pretax Income
-48588000
Annuals > 2 > income Statement > net Income
-48807000
Annuals > 2 > income Statement > eps
-1.5896339464542812
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
30703295
Annuals > 2 > income Statement > income Tax Expense
219000
Annuals > 2 > income Statement > EBITDA
-48841000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1600000
Annuals > 2 > balance Sheet > cash
17795000
Annuals > 2 > balance Sheet > short Term Investments
89321000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
108589000
Annuals > 2 > balance Sheet > property Plant Equipment
9724000
Annuals > 2 > balance Sheet > total Assets
118375000
Annuals > 2 > balance Sheet > payables
4473000
Annuals > 2 > balance Sheet > short Term Debt
2131000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
14968000
Annuals > 2 > balance Sheet > equity
103407000
Annuals > 2 > cash Flow > net Income
-48588000
Annuals > 2 > cash Flow > depreciation
1347000
Annuals > 2 > cash Flow > change In Working Capital
1008000
Annuals > 2 > cash Flow > cash From Operations
-39026000
Annuals > 2 > cash Flow > capital Expenditures
321000
Annuals > 2 > cash Flow > cash From Investing
49949000
Annuals > 2 > cash Flow > cash From Financing
-287000
Annuals > 2 > cash Flow > net Change In Cash
10636000
Annuals > 2 > ratios > PE
-1.5896339464542812
Annuals > 2 > ratios > PB
2.583177797441179
Annuals > 2 > ratios > ROE
-47.19893237401723
Annuals > 2 > ratios > ROA
-41.23083421330517
Annuals > 2 > ratios > FCF
-39347000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
685000
Annuals > 3 > income Statement > gross Profit
-685000
Annuals > 3 > income Statement > operating Expenses
36797000
Annuals > 3 > income Statement > operating Income
-37482000
Annuals > 3 > income Statement > interest Expense
670000
Annuals > 3 > income Statement > pretax Income
-36794000
Annuals > 3 > income Statement > net Income
-36794000
Annuals > 3 > income Statement > eps
-1.3277910189592563
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
27710686
Annuals > 3 > income Statement > income Tax Expense
670000
Annuals > 3 > income Statement > EBITDA
-35439000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
688000
Annuals > 3 > balance Sheet > cash
7159000
Annuals > 3 > balance Sheet > short Term Investments
140462000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
148542000
Annuals > 3 > balance Sheet > property Plant Equipment
4644000
Annuals > 3 > balance Sheet > total Assets
153225000
Annuals > 3 > balance Sheet > payables
2456000
Annuals > 3 > balance Sheet > short Term Debt
680000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
6712000
Annuals > 3 > balance Sheet > equity
146513000
Annuals > 3 > cash Flow > net Income
-36794000
Annuals > 3 > cash Flow > depreciation
685000
Annuals > 3 > cash Flow > change In Working Capital
117000
Annuals > 3 > cash Flow > cash From Operations
-30259000
Annuals > 3 > cash Flow > capital Expenditures
2026000
Annuals > 3 > cash Flow > cash From Investing
-143118000
Annuals > 3 > cash Flow > cash From Financing
163940000
Annuals > 3 > cash Flow > net Change In Cash
-9437000
Annuals > 3 > ratios > PE
-1.3277910189592563
Annuals > 3 > ratios > PB
1.645471515838185
Annuals > 3 > ratios > ROE
-25.113129892910525
Annuals > 3 > ratios > ROA
-24.01305270027737
Annuals > 3 > ratios > FCF
-32285000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-3.6224817448802415
Valuation > metrics > PB
0.46872819142000266
Valuation > final Score
70
Valuation > verdict
53.1% Undervalued
Profitability > metrics > ROE
-19.859173295084105
Profitability > metrics > ROA
-17.719604421175102
Profitability > metrics > Net Margin
0.9418676561533704
Profitability > final Score
30
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.19915677837179988
Risk > metrics > Interest Coverage
-808.5
Risk > final Score
-3174
Risk > verdict
High
Liquidity > metrics > Current Ratio
11.822558459422284
Liquidity > metrics > Quick Ratio
11.822558459422284
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
20
Prev Valuations > 2
23.94802778356692
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-2022
Prev Risks > 1
-2178
Prev Risks > 2
-1663
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:12:50.159Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-3.62
Earnings History > 0 > eps Estimate
-4.11
Earnings History > 0 > eps Difference
0.49
Earnings History > 0 > surprise Percent
11.9221
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-31
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-3.91
Earnings History > 1 > eps Estimate
-0.24
Earnings History > 1 > eps Difference
-3.67
Earnings History > 1 > surprise Percent
-1529.1667
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.2725
Earnings History > 2 > eps Estimate
-0.26
Earnings History > 2 > eps Difference
-0.0125
Earnings History > 2 > surprise Percent
-4.8077
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.2728
Earnings History > 3 > eps Estimate
-0.29
Earnings History > 3 > eps Difference
0.0172
Earnings History > 3 > surprise Percent
5.931
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-05
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.29
Earnings History > 4 > eps Estimate
-0.31
Earnings History > 4 > eps Difference
0.02
Earnings History > 4 > surprise Percent
6.4516
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-06
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.28
Earnings History > 5 > eps Estimate
-0.29
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
3.4483
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.32
Earnings History > 6 > eps Estimate
-0.28
Earnings History > 6 > eps Difference
-0.04
Earnings History > 6 > surprise Percent
-14.2857
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.3
Earnings History > 7 > eps Estimate
-0.31
Earnings History > 7 > eps Difference
0.01
Earnings History > 7 > surprise Percent
3.2258
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-07
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.28
Earnings History > 8 > eps Estimate
-0.34
Earnings History > 8 > eps Difference
0.06
Earnings History > 8 > surprise Percent
17.6471
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-03
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.31
Earnings History > 9 > eps Estimate
-0.33
Earnings History > 9 > eps Difference
0.02
Earnings History > 9 > surprise Percent
6.0606
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-09
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.33
Earnings History > 10 > eps Estimate
-0.36
Earnings History > 10 > eps Difference
0.03
Earnings History > 10 > surprise Percent
8.3333
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-28
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.4
Earnings History > 11 > eps Estimate
-0.4
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-08
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.44
Earnings History > 12 > eps Estimate
-0.37
Earnings History > 12 > eps Difference
-0.07
Earnings History > 12 > surprise Percent
-18.9189
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-09
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.34
Earnings History > 13 > eps Estimate
-0.39
Earnings History > 13 > eps Difference
0.05
Earnings History > 13 > surprise Percent
12.8205
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-10
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.4
Earnings History > 14 > eps Estimate
-0.35
Earnings History > 14 > eps Difference
-0.05
Earnings History > 14 > surprise Percent
-14.2857
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-10
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.3
Earnings History > 15 > eps Estimate
-0.34
Earnings History > 15 > eps Difference
0.04
Earnings History > 15 > surprise Percent
11.7647
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-09
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.32
Earnings History > 16 > eps Estimate
-0.24
Earnings History > 16 > eps Difference
-0.08
Earnings History > 16 > surprise Percent
-33.3333
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-04
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.32
Earnings History > 17 > eps Estimate
-0.29
Earnings History > 17 > eps Difference
-0.03
Earnings History > 17 > surprise Percent
-10.3448
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-12
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.42
Earnings History > 18 > eps Estimate
-0.3
Earnings History > 18 > eps Difference
-0.12
Earnings History > 18 > surprise Percent
-40
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-25
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-2.71
Earnings History > 19 > eps Estimate
-2.96
Earnings History > 19 > eps Difference
0.25
Earnings History > 19 > surprise Percent
8.4459
Earnings History > 20 > period
2019-09-30
Earnings History > 20 > report Date
2019-12-31
Earnings History > 20 > date
2019-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-20.8122
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-20.8122
Earnings History > 20 > surprise Percent
-
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. It also offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. It has a collaboration with The University of Washington to conduct preclinical studies for its solnerstotug program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADoes Empresa Nacional de Telecomunicaciones (SNSE:ENTEL) Have A Healthy Balance Sheet? simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$32.5
Analyst Picks
Strong Buy
2
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bearish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 7.20% of the total shares of Sensei Biotherapeutics Inc
1.
Vanguard Group Inc(2.3064%)
since
2025/06/30
2.
Ikarian Capital, LLC(1.7837%)
since
2025/06/30
3.
Catalio Capital Management, LP(1.1669%)
since
2025/06/30
4.
Vanguard Total Stock Mkt Idx Inv(0.4481%)
since
2025/07/31
5.
Fidelity Extended Market Index(0.3649%)
since
2025/07/31
6.
Vanguard Institutional Extnd Mkt Idx Tr(0.2713%)
since
2025/07/31
7.
UBS Group AG(0.1697%)
since
2025/06/30
8.
Fidelity Series Total Market Index(0.126%)
since
2025/07/31
9.
Fidelity Total Market Index(0.1123%)
since
2025/07/31
10.
NT Ext Equity Mkt Idx Fd - L(0.071%)
since
2025/06/30
11.
Northern Trust Extended Eq Market Idx(0.071%)
since
2025/06/30
12.
Nwf Advisory Services Inc(0.0655%)
since
2025/03/31
13.
Bank of America Corp(0.0462%)
since
2025/06/30
14.
Quint:Essence Strat Social Media&Tech P(0.0396%)
since
2025/07/31
15.
NT Ext Equity Mkt Idx Fd - NL(0.028%)
since
2025/06/30
16.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0217%)
since
2025/06/30
17.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0201%)
since
2025/06/30
18.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0169%)
since
2024/12/31
19.
Spartan Total Market Index Pool G(0.0145%)
since
2025/07/31
20.
State St US Extended Mkt Indx NL Cl C(0.0123%)
since
2025/08/31
21.
SBI Securities Co Ltd(0.0118%)
since
2025/06/30
22.
Fidelity Nasdaq Composite Index(0.0098%)
since
2025/07/31
23.
SSgA U.S. Total Market Index Strategy(0.0051%)
since
2025/03/31
24.
State St US Ttl Mkt Indx NL Cl A(0.0044%)
since
2025/08/31
25.
Northern Trust Wilshire 5000(0.0039%)
since
2025/06/30
26.
JPMorgan Chase & Co(0.0025%)
since
2025/06/30
27.
Spartan Extended Market Index Pool F(0.0025%)
since
2025/07/31
28.
Morgan Stanley - Brokerage Accounts(0.0008%)
since
2025/06/30
29.
BNP Paribas Arbitrage, SA(0.0007%)
since
2025/06/30
30.
Guggenheim Active Allocation Fund(0.0005%)
since
2025/05/31
31.
Deuterium Capital Management, LLC(0%)
since
2025/03/31
32.
State Street Corp(0%)
since
2025/06/30
33.
Susquehanna International Group, LLP(0%)
since
2025/03/31
34.
Tower Research Capital LLC(0%)
since
2025/06/30
35.
Northern Trust Corp(0%)
since
2025/06/30
36.
Bridgeway Capital Management, LLC(0%)
since
2025/03/31
37.
Barclays PLC(0%)
since
2025/06/30
38.
Citadel Advisors Llc(0%)
since
2025/03/31
39.
XTX Topco Ltd(0%)
since
2025/03/31
40.
HRT FINANCIAL LLC(0%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-3.62
EPS Estimate
-4.11
EPS Difference
0.49
Surprise Percent
11.9221%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.